甲氨蝶呤通过CD73/AMPK/mTOR通路恢复寻常型银屑病患者外周血调节性T细胞功能
研究从银屑病患者和健康对照者外周血分离调节性T细胞(Treg)与效应性T细胞(Teff),发现患者Treg免疫抑制功能下降且CD73表达降低;甲氨蝶呤可显著恢复分泌IL-17的Treg的免疫抑制功能,抑制Teff细胞异常增殖,上调CD73和磷酸化AMPK、抑制磷酸化mTOR,并下调IL-17和IFN-γ水平。作者推测甲氨蝶呤通过上调CD73、激活AMPK并失活mTOR通路恢复Treg功能,部分解释其治疗银屑病的机制。
要点
- 银屑病患者Treg免疫抑制功能下降且CD73表达低于健康对照。
- 甲氨蝶呤可显著恢复分泌IL-17的Treg的免疫抑制功能。
- 甲氨蝶呤上调CD73和磷酸化AMPK、抑制磷酸化mTOR,下调IL-17和IFN-γ。
核心结论
- 作者推测甲氨蝶呤通过上调CD73、激活AMPK并失活mTOR通路恢复Treg的免疫抑制功能,这些发现可能部分解释甲氨蝶呤治疗银屑病的机制。
研究设计与样本
- 从银屑病患者和健康对照者血液中分离调节性T细胞(Treg)与效应性T(Teff)细胞进行体外研究。
- 采用羧基荧光素琥珀酰亚胺酯(CFSE)检测Teff细胞增殖,酶联免疫吸附试验分析干扰素(IFN)-γ和白细胞介素(IL)-17水平,流式细胞术检测CD73和FoxP3表达,蛋白质印迹法检测AMPK/mTOR通路蛋白表达。
主要发现
- 与健康对照相比,银屑病患者Treg的免疫抑制功能下降且CD73表达降低。
- 甲氨蝶呤可显著恢复分泌IL-17的Treg的免疫抑制功能,进而抑制银屑病患者Teff细胞的异常增殖。
- 甲氨蝶呤逆转CD73的下调,上调磷酸化AMPK并抑制磷酸化mTOR,同时下调IL-17和IFN-γ水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Methotrexate (MTX) is used to treat psoriasis, a chronic inflammatory skin disease. OBJECTIVES: To investigate the molecular mechanism of MTX in the treatment of psoriasis. METHODS: Regulatory T cells (Tregs) and effector T (Teff) cells were isolated from the blood of patients with psoriasis and healthy controls. The proliferation of Teff cells was detected by carboxyfluorescein succinimidyl ester assay. The interferon (IFN)-γ and interleukin (IL)-17 levels were analysed by enzyme-linked immunosorbent assay. The expression of CD73 and FoxP3 were determined by flow cytometry. The expression of proteins in the AMPK/mTOR pathway were detected by Western blot analysis. RESULTS: The data suggested that patients with psoriasis have Tregs with decreased immune suppression function and reduced expression of CD73 compared with healthy controls. Moreover, MTX could significantly restore the immunosuppressive function of IL-17-secreting Tregs. This, in turn, inhibits aberrant proliferation of Teff cells in patients with psoriasis, reverses downregulation of CD73, upregulates phosphorylated AMPK and inhibits phosphorylated mTOR, and downregulates IL-17 and IFN-γ levels. CONCLUSIONS: We speculate that MTX can restore the immunosuppressive function of Tregs through upregulating CD73, activating AMPK and inactivating the mTOR pathway. These findings may partly explain the mechanism by which MTX treats psoriasis.
引用
- Yan K, Xu W, Huang Y, et al. Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73/AMPK/mTOR pathway. Br J Dermatol. 2018. PMID: 29572822. doi:10.1111/bjd.16560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。